Cargando…
Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems
BACKGROUND: Alzheimer’s disease (AD) is a progressive neurodegenerative disease that impacts nearly 400 million people worldwide. The accumulation of amyloid beta (Aβ) in the brain has historically been associated with AD, and recent evidence suggests that neuroinflammation plays a central role in i...
Autores principales: | Quiroga, I. Y., Cruikshank, A. E., Bond, M. L., Reed, K. S. M., Evangelista, B. A., Tseng, J. H., Ragusa, J. V., Meeker, R. B., Won, H., Cohen, S., Cohen, T. J., Phanstiel, D. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034485/ https://www.ncbi.nlm.nih.gov/pubmed/35459147 http://dx.doi.org/10.1186/s12974-022-02459-1 |
Ejemplares similares
-
Accumulation of Innate Amyloid Beta Peptide in Glioblastoma Tumors
por: Kucheryavykh, Lilia Y., et al.
Publicado: (2019) -
Amyloid beta is an early responder cytokine and immunopeptide of the innate immune system
por: Weaver, Donald F.
Publicado: (2020) -
CRANAD-28: A Robust Fluorescent Compound for Visualization of Amyloid Beta Plaques
por: Ran, Kathleen, et al.
Publicado: (2020) -
Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023) -
Synthetic Fragments of Receptor for Advanced Glycation End Products Bind Beta-Amyloid 1–40 and Protect Primary Brain Cells From Beta-Amyloid Toxicity
por: Kamynina, Anna V., et al.
Publicado: (2018)